Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,124 | -8,623 | -26,608 | -18,909 | -11,586 |
| Depreciation Amortization | 189 | 89 | 433 | 346 | 182 |
| Accounts payable and accrued liabilities | -1,009 | -261 | 2,133 | 862 | 713 |
| Other Working Capital | 140 | 594 | 3,077 | 1,634 | 368 |
| Other Operating Activity | 1,980 | 729 | -685 | 222 | 23 |
| Operating Cash Flow | $-13,824 | $-7,472 | $-21,650 | $-15,846 | $-10,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,555 | 1,555 | 1,555 |
| PPE Investments | -118 | -69 | -738 | -618 | -392 |
| Investing Cash Flow | $-118 | $-69 | $817 | $937 | $1,163 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 29,006 | 28,992 | 28,971 |
| Financing Cash Flow | $N/A | $N/A | $29,006 | $28,992 | $28,971 |
| Beginning Cash Position | 35,029 | 35,028 | 26,856 | 26,856 | 26,856 |
| End Cash Position | 21,087 | 27,487 | 35,029 | 40,939 | 46,690 |
| Net Cash Flow | $-13,942 | $-7,541 | $8,173 | $14,083 | $19,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,824 | -7,472 | -21,650 | -15,846 | -10,300 |
| Capital Expenditure | -119 | -69 | -738 | -618 | -392 |
| Free Cash Flow | -13,943 | -7,541 | -22,388 | -16,464 | -10,692 |